450
Participants
Start Date
November 3, 2016
Primary Completion Date
December 31, 2025
Study Completion Date
December 31, 2025
Fenofibrate
145 mg tablet of fenofibrate administered once daily for 36 months.
Inert lactose placebo
Insert lactose tablet matching active tablet administered once daily for 36 months.
RECRUITING
Auckland Diabetes Centre, Auckland
RECRUITING
Garvan Institute of Medical Research, Darlinghurst
RECRUITING
Prince of Wales Hospital, Randwick
RECRUITING
Royal Prince Alfred Hospital, Camperdown
RECRUITING
Royal North Shore Hospital, Saint Leonards
RECRUITING
Concord Repatriation General Hospital, Concord
RECRUITING
Retina Associates - South West Retina, Liverpool
RECRUITING
Hunter Diabetes Centre, Merewether
RECRUITING
Canberra Hospital, Garran
RECRUITING
Baker Heart and Diabetes Institute, Melbourne
RECRUITING
Sunshine Hospital, St Albans
RECRUITING
The Royal Melbourne Hospital, Parkville
RECRUITING
St Vincent's Hospital Melbourne, Melbourne
RECRUITING
Heidelberg Repatriation Hospital, Heidelberg
RECRUITING
University Hospital Geelong, Geelong
RECRUITING
Mater Adult Hospital, South Brisbane
RECRUITING
Princess Alexandra Hospital, Woolloongabba
RECRUITING
Cairns Hospital, Cairns
RECRUITING
Royal Adelaide Hospital, Adelaide
RECRUITING
Southern Adelaide Diabetes and Endocrine Services, Oaklands Park
RECRUITING
Fremantle Hospital, Fremantle
RECRUITING
Christchurch Hospital, Christchurch
RECRUITING
Prince of Wales Hospital, Shatin
RECRUITING
Belfast Health and Social Care Trust, Belfast
Collaborators (1)
National Health and Medical Research Council, Australia
OTHER
Juvenile Diabetes Research Foundation Australia
UNKNOWN
Mylan Pharmaceuticals Inc
INDUSTRY
University of Sydney
OTHER